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Abstract
Background: β-catenin is an essential mediator of canonical Wnt signaling and a central component of the
cadherin-catenin epithelial adhesion complex. Dysregulation of β-catenin expression has been described in
pancreatic neoplasia. Newly published studies have suggested that β-catenin is critical for normal pancreatic
development although these reports reached somewhat different conclusions. In addition, the molecular
mechanisms by which loss of β-catenin affects pancreas development are not well understood. The goals of this
study then were; 1] to further investigate the role of β-catenin in pancreatic development using a conditional
knockout approach and 2] to identify possible mechanisms by which loss of β-catenin disrupts pancreatic
development. A Pdx1-cre mouse line was used to delete a floxed β-catenin allele specifically in the developing
pancreas, and embryonic pancreata were studied by immunohistochemistry and microarray analysis.
Results: Pdx1-cre floxed β-catenin animals were viable but demonstrated small body size and shortened median
survival. The pancreata from knockout mice were hypoplastic and histologically demonstrated a striking paucity
of exocrine pancreas, acinar to duct metaplasia, but generally intact pancreatic islets containing all lineages of
endocrine cells. In animals with extensive acinar hypoplasia, putative hepatocyte transdifferention was occasionally
observed. Obvious and uniform pancreatic hypoplasia was observed by embryonic day E16.5. Transcriptional
profiling of Pdx1-cre floxed β-catenin embryonic pancreata at E14.5, before there was a morphological phenotype,
revealed significant decreases in the β-catenin target gene N-myc, and the basic HLH transcription factor PTF1,
and an increase of several pancreatic zymogens compared to control animals. By E16.5, there was a dramatic loss
of exocrine markers and an increase in Hoxb4, which is normally expressed anterior to the pancreas.
Conclusion: We conclude that β-catenin expression is required for development of the exocrine pancreas, but
is not required for development of the endocrine compartment. In contrast, β-catenin/Wnt signaling appears to
be critical for proliferation of PTF1+ nascent acinar cells and may also function, in part, to maintain an
undifferentiated state in exocrine/acinar cell precursors. Finally, β-catenin may be required to maintain positional
identity of the pancreatic endoderm along the anterior-posterior axis. This data is consistent with the findings of
frequent β-catenin mutations in carcinomas of acinar cell lineage seen in humans.
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Background
Over the past several years, key transcription factors and
signaling pathways that mediate pancreatic development
have become increasingly well-defined [1]. The canonical
Wnt signaling pathway has been shown to play a critical
role in the development of numerous tissues, and when
inappropriately activated, it plays a central role in tumor-
igenesis [2-5]. Prior studies have suggested the importance
of Wnt signaling in pancreatic development, as expression
of Wnt1 under control of the Pdx-1 promoter was associ-
ated with murine pancreatic agenesis [6]. Another study
demonstrated that numerous Wnt pathway genes are
expressed during pancreatic organogenesis [7]. Recently
published studies from two laboratories examined the
effects of deleting β-catenin, the central mediator of
canonical Wnt signaling, in the mouse pancreas and
reported somewhat conflicting findings. One study sug-
gested that β-catenin/Wnt signaling was essential for
development of exocrine pancreas, but played no role in
endocrine development, while the other concluded that
the loss of β-catenin/Wnt signaling in the developing
mouse resulted in transient pancreatitis, but ultimately
found that exocrine pancreas eventually recovered [8,9].
Furthermore, this study found a decrease in islet cell num-
bers in β-catenin knockout mice suggesting a significant
role for the Wnt pathway in endocrine lineage develop-
ment. It is still not clear why these reports reached differ-
ent conclusions, nor have the molecular pathways that act
downstream of β-catenin in the pancreas been identified.
We have utilized similar transgenic methods to delete β-
catenin expression from the developing mouse pancreas.
In addition, we have examined the effects of blocking Wnt
signaling in dorsal pancreatic explants using a specific
biochemical inhibitor PKF118–310. Finally we compre-
hensively investigated the molecular consequences of
deletion of β-catenin on embryonic pancreas develop-
ment using transcriptional profiling. We analyzed embry-
onic pancreata at E14.5, before the pancreas was
phenotypically affected, and at E16.5, when hypoplasia of
the exocrine pancreas is evident. Our studies reveal that
deletion of β-catenin during pancreatic development
results in decreased body size of the knockout animals in
association with severe pancreatic hypoplasia and short-
ened median survival. The hypoplastic pancreas is marked
by striking absence of exocrine mass, with preservation of
pancreatic islets. Pancreatic buds exposed to a Wnt inhib-
itor also demonstrate decreased expression of exocrine-
specific genes, suggesting that the Wnt signaling function
of β-catenin is responsible for the defect in exocrine devel-
opment. Proliferation of exocrine cells is significantly
reduced, suggesting that Wnt signaling promotes exocrine
cell proliferation during development. Transcriptional
profiling and quantitative RT-PCR of embryonic pancre-
ata reveal significant down regulation of the transcription
factor PTF1 as early as E12.5. Down regulation of the Wnt
target gene N-myc and the FGFR2 gene was observed in
knockout animals which correlates with the decreased
proliferation of nascent exocrine cells and may be respon-
sible for the observed phenotype [10]. Interestingly at
E14.5, there is also a significant increase in the levels of
the exocrine genes elastase, and amylase, suggesting that
the absence of a Wnt signal may cause precocious differ-
entiation of exocrine progenitor cells. Together, our find-
ings strongly support a critical role for β-catenin in
exocrine, but not endocrine development and suggest sev-
eral Wnt-dependent putative regulators of exocrine cell
proliferation and differentiation during normal pancre-
atic development.
Methods
Generation of genetically modified mice
Mice containing a floxed allele of β-catenin were a gener-
ous gift of the Birchmeier laboratory. The β-catenin allele
in this animal contains LoxP sites in the second and sixth
intron as described [11]. To obtain conditional deletion
of β-catenin within the pancreas, we utilized a Pdx1-cre
transgenic strain, developed in our laboratory, and previ-
ously reported to mediate efficient recombination in the
developing mouse pancreas by E10.5 [12]. Mice were gen-
otyped using PCR on digests of ear clippings. To identify
Cre, the following primers were used to amplify a 475-bp
product: forward 5'-AGATGTTCGCGATTATCTTC-3';
reverse 5'-AGCTACACCAGAGACGG-3'.
The PCR conditions were 94°C for 3 min, then 30 cycles
at 94°C for 30 s, 58°C for 45 s, and 72°C for 45 s, fol-
lowed by 72°C for 5 min. To identify β-catenin lox ani-
mals, the following primers amplify a 150-bp product for
wild-type, and a 200-bp product for lox mice: forward 5'-
ACTGCCTTTGTTCTCTTCCCTTCTG-3'; reverse 5'-
CAGCCAAGGAGAGCAGGTGAGG-3' [11]. The PCR con-
ditions were 94°C for 3 min, then 30 cycles at 94°C for 30
s, 63°C for 45 s, and 72°C for 45 s, followed by 72°C for
5 min. The addition of a final concentration of 1.2 M
betaine [Sigma-Aldrich, St. Louis, MO] enhanced the reac-
tion. Timed pregnancies were determined by estimating
that the detection of vaginal plugs occurred on E 0.5.
Tissue processing
Mice were euthanized using isoflurane. Pancreata were
dissected and placed in PBS, fixed in formalin followed by
processed in paraffin wax and sectioned at 4 μm. For fro-
zen sections, tissues were fixed for 2 hours at 4°C in 4%
paraformaldehyde, washed in cold PBS and placed over-
night in 30% sucrose [w/v] in PBS, prior to embedding
and freezing in OCT.BMC Developmental Biology 2007, 7:4 http://www.biomedcentral.com/1471-213X/7/4
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Immunostaining
Dewaxed sections were subjected to antigen unmasking
with Citrate solution pH 6. [Invitrogen Inc., Carlsbad,
CA]. Slides were incubated in 0.3% hydrogen peroxide/
methanol and then blocked with Beat Block, from Histo-
Mouse max kit [Invitrogen Inc.] Primary antibody Anti-
Active-β-Catenin [anti-ABC] clone 8E7 [Upstate, Char-
lottesville, VA] at 1:100 was applied O/N, 4°C. Secondary
antibody, chromagen and counterstain were provided and
the manufacturer's protocol was used. Primary antibodies
to albumin [Abcam Inc., Cambridge, MA] and amylase
[Sigma-Aldrich, St. Louis, MO] were incubated with slides
at 1:3000 and 1:500, respectively, 1 hr R/T after citrate
epitope retrieval, avidin and biotin blocking [Invitrogen
Inc.]. Nonspecific binding was blocked with appropriate
serum incubations for 30 minutes. Biotin conjugated sec-
ondary antibodies [Invitrogen, Inc.] were applied 30 min-
utes R/T followed by incubation with HRP Streptavidin 15
minutes and visualized with DAB [3, 3-diaminobenzi-
dine, Dako, Carpinteria, CA]. They were counterstained
with Mayer hematoxylin. Apoptotic cells were detected by
flourescein in situ tunnel method, TACS TdT kit [R&D Sys-
tems, Minneapolis, MN]. Proteinase K was used for
epitope retrieval and all steps were performed according
to manufacturer's protocol.
Immunofluorescent staining
For immunolabeling, tissues were sectioned and fixed in
4% PFA for 15 minutes at room temperature, washed in
PBS and stained as previously described [Esni et al., 2001].
The following antibodies were used at the indicated dilu-
tions; rat monoclonal anti-E-cadherin [Zymed Laborato-
ries, 1:200], goat polyclonal anti-amylase [Santa Cruz
Biotechnology, 1:500], goat polyclonal anti-β-catenin
[Santa Cruz Biotechnology, 1:100], guinea pig polyclonal
anti-insulin [Linco Research, 1:1000], rabbit polyclonal
anti-Pdx1 [CHEMICON International, 1:250] rabbit poly-
clonal anti-PTF1a-p48 [gift from Dr. Helena Edlund,
1:1000], rabbit anti-phosphohistone H3 [Upstate 65–
570, 1:200]. The following reagents were purchased from
Jackson ImmunoResearch Laboratories: Biotin-conju-
gated anti-goat, anti-guinea pig [1:250, 1:500], Cy3-con-
jugated anti-rabbit [1:300], Cy2-conjugated anti-rat
[1:300], and Cy2-, Cy3-, C5-conjugated streptavidin
[1:300, 1:1000, 1:100].
Explant culture of embryonic pancreas
Isolation and culture of pancreatic rudiments were carried
out essentially as previously described [13]. Intact E10.5
dorsal pancreatic buds were dissected and cultured on
Millipore® filters for 7 days in culture medium [BioWhit-
taker Medium 199, 10% fetal calf serum, 50 U/ml penicil-
lin G-streptomycin, 1.25 ug/ml Fungizone®] in the
presence or absence of 20 nM Wnt-pathway inhibitor
compound PKF118–310 [ref]. Culture medium was
changed every day and by the end of the culture period,
explants were either embedded in OCT and frozen in liq-
uid nitrogen for immunostaining analysis or put in TRI-
zol® Reagent for total RNA extraction.
RNA isolation and microarray hybridization
Pancreata were dissected from 12.5, 14.5 and 16.5 day
embryos taken from timed matings of Pdx1-cre floxed β-
catenin  mice and immediately submerged in RNAlater
[Ambion, Inc., Austin, TX]. Total RNA was purified using
RNeasy columns [Qiagen, Valencia, CA] according to the
manufacturer's directions and quality was assessed using
an Agilent 2100 Bioanalyzer [Agilent Technologies, Inc.,
Palo Alto, CA]. 120 ng of total RNA from 2 wild type [WT]
and 4 β-catenin knock-out [KO] pancreata at the 14.5 and
16.5 time points was amplified twice with the Arcturus
RiboAmp kit [Arcturus Bioscience, Inc., Mountain View,
CA] and cRNA was labeled with biotin-UTP, CTP using T7
RNA polymerase [Enzo Life Sciences, Inc., Farmingdale,
NY]. Biotinylated cRNA from each embryonic pancreas
was purified with RNeasy columns and hybridized to an
Affymetrix GeneChip mouse genome 430 v2.0 array and
stained using standard procedures [Affymetrix, Santa
Clara, CA]. The 430 v2.0 array contains 45,000 probe sets
representing over 34,000 mouse genes.
Bioinformatics
We sought to identify genes whose expression was lost or
gained as a result of loss of β-catenin gene expression. To
do this, microarrays were generated from RNAs isolated
from independent wildtype and knockout embryos as
previously described. Affymetrix MOE430plus2 micro-
array Cel files generated from GCOS 5.0 were subjected to
RMA normalization as implemented in GeneSpring 7.1.
All E14.5 genechip RMA values were converted to the ratio
relative the average of the corresponding day wildtype val-
ues. In this fashion one does not see the effect of increased
or decreased expression in WT E16.5 relative to WT E14.5.
Probe sets were first filtered for those that are over-
expressed or underexpressed in knockout animals at
E14.5 [486 probesets; initial criteria over 1.25 in 3 of 4
samples or under 0.66 in 3], and the same for E16.5 [513
probesets, initial criteria over 1.33 in 4 or under 0.5 in 4].
These two lists were combined [967] and then subjected
to statistical analysis differentially expression in knock-
outs with p < 0.05 using the Students T-test assumption of
equal distribution and Benjamini-Hochberg false discov-
ery corrected p-values. This procedure generated a list of
770 probe sets. Log2 gene expression ratios were then sub-
jected to hierachical clustering using the standard correla-
tion distance metric as implemented in GeneSpring.
Individual clusters were then analyzed for functional
relatedness of genes within the cluster using David 2.0.BMC Developmental Biology 2007, 7:4 http://www.biomedcentral.com/1471-213X/7/4
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Quantitative RT-PCR
For quantitative RT-PCR, total RNA was purified and char-
acterized as described above. 500 to 1000 ng of RNA was
converted to cDNA using random hexamers and Super-
script III [Invitrogen, Carlsbad, CA]. Amplification was
carried out with an ABI 7300 real time PCR system
[Applied Biosystems, Foster City, CA] using SYBR green
and the standard protocol. The reference gene was β-glu-
curonidase for all genes except Ptf1, for which Gapdh was
used. Data was normalized using the delta-delta-Ct
method. Whenever possible, primers were designed to
span an intronic sequence and were validated by PCR and
gel analysis.
Primer sequences were as follows:
β-glucuronidase
5'-TTGAGAACTGGTATAAGACGCATCAG-3' forward
5'-TCTGGTACTCCTCACTGAACATGC-3' reverse
Gapdh
5'-AATGGTGAAGGTCGGTGTG-3' forward
5' GAAGATGGTGATGGGCTTCC 3' reverse
Amylase
5'-GGTTCTCCCAAGGAAGCAG-3' forward
5'-TGTCACACGGCCATTTCC-3' reverse
Elastase
5'-CATCCAGACAGCTTGCCTC-3' forward
5'-CTCAGGGTGTCAGGACTGTTC-3' reverse
Fgfr2
5'-AAGCAGGAGCATCGCATTGG-3' forward
5'-TGACGGGACCACACTTTCCATA-3' reverse
N-myc
5'-CTCAAGTCAGTGCAGGCGAG-3' forward
5'-CCACCGTTACGACATCAATCTC-3' reverse
Ptf1
5'-CAGGCCCAGAAGGTTATCATCTG-3' forward
5'-AGGAAAGAGAGTGCCCTGCAAG-3' reverse
Results
β-catenin knockout results in small body size, severe 
pancreatic hypoplasia and early lethality
We achieved pancreas-specific deletion of β-catenin by
breeding a Pdx1-cre  strain developed in our laboratory
with a strain containing a floxed β-catenin allele in the sec-
ond and sixth intron [11,12]. Pdx1-cre mice heterozygous
for the floxed β-catenin  allele displayed no apparent
abnormalities in either the embryonic or adult pancreas.
Mice with conditional knockout of both β-catenin alleles
in the pancreas [Pdx1-cre floxed β-catenin] were viable, but
demonstrated small body size at birth that persisted into
adulthood. For simplicity, these animals are referred to as
β-catenin KO in the remainder of the text. β-catenin KO
mice showed no obvious defects in their ability to nurse
or wean, but had a significantly shortened lifespan, with a
median survival of 29 days [Figure 1A–B]. Several mice
did survive to greater than 6 months. Necropsy revealed
no gross defects in development of the stomach, duode-
num, colon, spleen or other organs. The pancreata, how-
ever, were severely hypoplastic, averaging 30% of the
Pancreas-specific deletion of β-catenin results in shortened  lifespan and a hypoplastic gland Figure 1
Pancreas-specific deletion of β-catenin results in 
shortened lifespan and a hypoplastic gland. β-catenin 
KO mice have a median survival of 29 days [A], reduced 
body size [B] and the pancreas averages 30% of the weight of 
a wildtype organ [C].BMC Developmental Biology 2007, 7:4 http://www.biomedcentral.com/1471-213X/7/4
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weight of pancreata from wildtype littermates [Figure 1C].
Although the cause of death is not known, we have deter-
mined that it is not due to defects in endocrine pancreas
function [discussed below].
β-catenin knockout results in loss of exocrine pancreatic 
tissue
To determine the effects of β-catenin deletion on pancre-
atic morphology, we examined pancreata by standard
H&E staining. At birth, pancreatic tissues from the condi-
tional β-catenin knockout mice had were characterized by
a striking paucity of acinar cell mass, numerous tubular
structures suggesting acinar to duct metaplasia. In addi-
tion, we observed increased parenchymal fibrosis, and a
variable degree of surrounding inflammatory infiltrate,
which became more severe by one month of age [Figure
2A–F]. The phenotype progressed with age as the pancre-
ata from mice surviving longer than 2 months often dem-
onstrated near complete absence of acinar cell structures
[Figure 2G–H]. The inflammatory infiltrate associated
with the intralobular fibrosis was reminiscent of acute on
chronic pancreatitis. In four animals of 23 (17%) exam-
ined that survived beyond three months, the pancreatic
harvested at necropsy had a liver-like histology on H&E,
suggesting the possibility of hepatic transdifferentiation.
Immunostaining of these tissues was positive for albumin
demonstrating that a liver-like differentiation program
may be activated in these tissues [Figure 2I–K].
Pancreatic islets cells are preserved in the β-catenin 
knockout
Pancreatic islet cell number was quantitated in wildtype
and β-catenin KO mice by counting islets in serial pancre-
atic sections from newborn mice. We found no significant
difference in islet cell numbers suggesting endocrine
development is preserved in the β-catenin KO mouse
[data not shown]. Endocrine cells were further character-
ized by immunostaining for insulin and glucagon. These
studies revealed that despite the absence of β-catenin
expression, insulin and glucagon cells were present and
normally distributed within the islets [Fig 3A–F]. Three
separate fasting glucose levels were obtained from 6 one
month-old β-catenin KO mice. All mice were found to be
euglycemic [data not shown]. This constellation of find-
ings suggest that no significant defect in endocrine devel-
opment following deletion of β-catenin from the
developing mouse pancreas.
β-catenin function is required prior to E16.5 in pancreatic 
development
We next analyzed pancreata from β-catenin KO mice
beginning at ED 12.5 to determine when pancreatic devel-
opment was perturbed. We noted no obvious difference
in the size of pancreata until E16.5, at which point loss of
β-catenin results in an obvious and consistent decrease in
pancreatic mass, corresponding to a decrease in the
number of recognizable nascent acini [Figure 4A–B].
This finding led us to hypothesize that in normal pancre-
atic development, the presence of Wnt signaling would be
critical prior to E16.5. To explore this idea, we examined
embryonic pancreas for expression of the dephosphor-
ylated, active form of β-catenin using a phospho-specific
antibody. We detected activated β-catenin protein expres-
sion at E12.5 that remained at E14.5 but then rapidly dis-
appeared by E16.5 Figure [4C–E]. Dephosphorylated β-
catenin protein expression was primarily membranous
and cytoplasmic but rarely nuclear, a finding also reported
by Murtaugh et al. [8]. This data suggest that Wnt signal-
ing is active in developing pancreas prior to the secondary
transition and that exocrine development likely requires
Wnt activity until E16.5, but not later as transcriptionally
active dephosphorylated β-catenin is undetectable there-
after.
Preserved acini express β-catenin
Given that the β-catenin KO was based on conditional
activation of the cre recombinase expressed from a trans-
genic allele, it is likely that cre expression was mosaic.
While the majority of the acinar pancreas was absent, it
was striking that there were clusters of normal appearing
acini. Therefore, we hypothesized that the presence of pre-
served acini would correspond to the presence of β-cat-
enin expression. This proved to be the case as essentially
all acini were found to express β-catenin. Co-staining for
β-catenin/carboxypeptidase A in E 12.5 pancreata [Figure
5A] revealed that pancreatic enzyme expression is present
only in cells co-expressing β-catenin. It was extremely rare
(<1% of acini) to identify expression of pancreatic acini in
the absence of β-catenin expression strongly suggesting
the requirement o β-catenin expression for proper exo-
crine development.
Pancreatic progenitor cells expressing Pdx1 are 
maintained in the β-catenin KO pancreas
We next sought to evaluate whether deletion of β-catenin
influenced the development of pancreatic progenitors
expressing Pdx1. In other genetically modified mice, pan-
creatic hypoplasia has been associated with a reduction in
the Pdx1-expressing progenitor cells [14]. We analyzed
pancreata at E12.5 and found no difference in the number
of cells expressing Pdx1 in the β-catenin KO versus the
wildtype [Figure 6A]. Next, we evaluated the expression of
PTF1A-p48, whose expression become restricted to exo-
crine cells at approximately E12.5. As early as E14.5, β-cat-
enin KO pancreata displayed reduced expression of PTF1
protein [Figure 6B]. This data demonstrates that the defect
in exocrine pancreatic development observed in the β-cat-
enin KO is not a result of depletion of Pdx1 expressing
progenitors. Instead, a population of cells marked by highBMC Developmental Biology 2007, 7:4 http://www.biomedcentral.com/1471-213X/7/4
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β-catenin KO pancreata display extensive loss of exocrine tissue Figure 2
β-catenin KO pancreata display extensive loss of exocrine tissue. Hematoxylin and eosin stained paraffin sections 
were used to compare the histology of wildtype versus β-catenin KO pancreata at one day, one month and two months of age. 
Compared to one day old wildtype pancreas [A], the absence of acini is readily apparent at low power [D]. At two months of 
age, compared to wildtype [B, C] the β-catenin KO pancreas is hypoplastic with increased areas of interlobular fibrosis [E]. 
Under 20× magnification, increased formation of tubular duct-like structures are present suggesting acinar to duct metaplasia 
(arrows) and inflammatory infiltrate (circled) are evident [F and H]. By two months, low power views demonstrate extensive 
fibrosis and near complete absence of exocrine pancreatic tissue, likely accounting for the shortened lifespan seen in these ani-
mals [E and G]. In several mice aged beyond three months, areas of pancreatic parenchyma histologically resemble liver. Immu-
nostaining for albumin is absent in wildtype pancreas  [J], but abundant in normal liver [I] and in β-catenin KO pancreata [K].BMC Developmental Biology 2007, 7:4 http://www.biomedcentral.com/1471-213X/7/4
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PTF1A-p48 expression is severely reduced in the β-catenin
KO mouse.
Proliferation rate, not apoptosis distinguishes β-catenin 
KO pancreata from wildtype
In order to determine if the loss of acinar cells in the β-cat-
enin knockout was related to a decrease in proliferation of
β-catenin-deficient cells, we performed immunostaining
of β-catenin KO and wildtype pancreata at ED 14.5 using
an antiphosphohistone H3 antibody [Figure 7]. These
studies revealed a significantly decreased proliferation
rate in the β-catenin KO versus wildtype [28.2% vs. 48.6%
p < 0.05, t-test]. We also evaluated for the presence of
apoptosis within the β-catenin KO animals using a
TUNEL assay, but did not find any significant differences
between wildtype and knockout animals [data not
shown]. These findings suggest that β-catenin expression
is required for proliferation, rather than apoptotic resist-
ance of exocrine progenitors.
Wnt inhibitors result in decreased amylase expression in 
dorsal pancreatic explants
Thus far, we have demonstrated that deletion of β-catenin
is associated with a defect in exocrine development, pos-
sibly related to decreased proliferation of exocrine pro-
genitors. It is probable that such a defect relates to a
decrease in the Wnt signaling function of β-catenin, given
the temporal expression of dephosphorylated β-catenin at
this stage in the developing pancreas. However, β-catenin
also functions in the E-cadherin-catenin cell adhesion
complex and it is therefore possible that part of the phe-
notype we have observed is related to this function of β-
catenin [15]. To investigate this possibility, we cultured
explants from E10.5 dorsal pancreatic buds for 7 days in
the presence of a specific inhibitor of β-catenin/Tcf tran-
scription, PKF118–310 [16]. Typically, E10.5 dorsal pan-
creatic explant cultures robustly express exocrine markers
after 7 days in culture [13]. In contrast, inhibition of Wnt
signaling in dorsal bud explants results in a significant
decrease in expression of amylase, similar to the findings
observed in vivo [Figure 8]. When the inhibitor was
applied after 3 days, no significant effect was observed,
suggesting that the importance of Wnt signaling in this
system is restricted to the first 3 days in culture. These data
provide additional evidence that the Wnt signaling func-
tion of β-catenin is required to regulate exocrine cell pro-
liferation and differentiation in the fetal pancreas. The
persistence of PTF1 protein expression in vitro may reflect
onset of its expression prior to inhibitor addition. Alterna-
tively, loss of PTF1 expression that we observed in vivo
may be regulated by a Wnt independent function of β-cat-
enin. Finally, these experiments do not rule out a role for
β-catenin in cell adhesion in vivo at later stages of devel-
opment or in the adult.
Endocrine cells are preserved in the absence of β-catenin Figure 3
Endocrine cells are preserved in the absence of β-catenin. Immunofluorescent staining of E15.5 comparing wildtype [A-
C] and β-catenin KO [D-F] demonstrates preservation of insulin and glucagon expressing cells in the β-catenin KO [CKO].BMC Developmental Biology 2007, 7:4 http://www.biomedcentral.com/1471-213X/7/4
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Transcriptional profiling reveals significant changes in 
gene expression following deletion of β-catenin
Although β-catenin has been shown to be necessary for
proper pancreas development, the molecular pathways
that are perturbed downstream of β-catenin are largely
unidentified. Targets of β-catenin/Tcf transcription have
been demonstrated to be tissue specific [17,18]. Given our
findings that β-catenin KO inhibits exocrine pancreatic
development, we sought to identify targets of β-catenin/
Tcf transcription that are changed in association with the
β-catenin KO. We chose to assay the whole pancreas tran-
scriptome at two timepoints, E14.5 and E16.5. These
stages were chosen for two reasons, first there is a marked
change in β-catenin expression around the secondary
transition; expression of dephospho-β-catenin is high at
E14.5 and it is absent at E16.5. Second, there is no mor-
phological phenotype at E14.5 whereas at E16.5 there is
significant exocrine hypopalsia. We harvested the embry-
onic pancreas from two wildtype, and four β-catenin KO
mice at E14.5 and E16.5, and extracted total RNA for stud-
ies using Affymetrix GeneChips and quantitative RT-PCR
[QPCR]. Analysis of the transcriptional profiles demon-
strated significance differences between wildtype and β-
catenin KO pancreata at each timepoint [Figure 9A, Table
1]. There was more variability in the E14.5 sample, possi-
bly due variability in harvesting these smaller pancreata or
β-catenin KO pancreas is hypoplastic by E16.5 Figure 4
β-catenin KO pancreas is hypoplastic by E16.5. Panels A and B depict hematoxylin and eosin staining of E 16.5 wildtype 
and β-catenin KO pancreas, respectively, each at 25× magnification. Hypoplasia of the developing pancreas is already apparent 
and was consistently present by this stage. Panels C, D, and E demonstrate wild-type pancreata at E 12.5, 14.5 and 16.5, respec-
tively, stained with an antibody specific for the transcriptionally active, dephosphorylated form of β-catenin. Note that staining 
is abundant at ED12.5, but is undetectable following the secondary transition at E16.5.BMC Developmental Biology 2007, 7:4 http://www.biomedcentral.com/1471-213X/7/4
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due to stage variation as the developmental range of an
E14.5 embryo is significant. Also, this is when the second-
ary transition is occurring and one might normally expect
to see many gene expression changes at this stage of pan-
creatic development. As a result, we used less stringent ini-
tial criteria for filtering transcripts that might be regulated
by β-catenin [see Methods]. Clustering revealed very good
consistency, and in all, 770 probe sets that mapped to 645
non-redundant genes were identified as differentially
expressed between wildtype and either or both of these
time points. The most differentially expressed genes at
each time point are summarized in Tables 1, 2, 3, 4. Gene-
Chip and QPCR were congruent with our immunostain-
ing findings as Pdx1  transcript levels did not differ
between wildtype and β-catenin KO. Expression of PTF1
transcript was reduced in the β-catenin KO at E14.5 by
microarray and as early as E12.5 by QRT-PCR [Figure 9B].
We observed no change in expression of the canonical
Wnt target genes Cyclin D1 or C-myc by either RNA assay
(data not shown). Instead, our studies revealed a signifi-
cant decrease in expression of N-myc at both time points
[decreased by 2 fold at E14.5]. Consistent with this, N-myc
was only recently shown to be a direct target of Wnt sign-
aling in the lung [10]. GeneChip studies also revealed a
1.7 fold decrease in the expression of transcripts encoding
Fgfr2 at E14.5, consistent with the role of this receptor in
exocrine pancreas development [19]. QPCR confirmed
decreases in these transcripts in the β-catenin KO mouse
[Figure 10A-D].
Other notable genes significantly reduced at E14.5
included musashi homolog 2 (Msi2h) [2 fold], an RNA
binding protein implicated in maintaining the identity of
progenitor cell fates in the brain [20] and hedgehog-inter-
acting protein [Hhip] [1.9 fold] suggesting a potential role
for this signaling pathways in exocrine pancreatic devel-
opment. A transcription factor of unknown function, the
leucine zipper-like transcription factor1 (Lzltf1), was
among the most reduced genes at E14.5, with its expres-
sion being decreased by an average of 5.9 fold. Hox b4
was significantly increased in E16.5 β-catenin mutant
pancreata suggesting that loss of Wnt signaling results in a
partial homeotic transformation [21]. This is further sup-
ported by the appearance of albumin-expressing cells in
the adult pancreas [Figure 2I].
Among the transcripts most down regulated in E16.5 β-
catenin KO mutants included acinar cell specific genes
such as pancreatic elastase (Ela3b), and trypsin (Try4).
Interestingly, at E14.5, the transcript for pancreatic
elastase (Ela3b) was upregulated an average of 11.3 fold,
and the transcript for pancreatic amylase2 (Amy2) was
upregulated an average of 2.3 fold. QPCR confirmed the
upregulation of transcripts at E14.5 as compared to
wildtype, and demonstrated the reversal of this pattern by
E16.5 [Figure 10B]. Interestingly, immunostaining did
not reveal increases in elastase or amylase protein levels at
E14.5. Uniformly, however, all exocrine gene transcripts
were dramatically down regulated by E16.5 compared to
wildtype. These data suggest that the tight control
between proliferation and differentiation is perturbed in
β-catenin mutants. Despite the lack of an endocrine phe-
notype in the β-catenin KO mice, we did observe upregu-
lation of transcripts for insulin I (Ins1) [4.7 fold], and a
slight increase in glucagon (Gcg) [1.4 fold] at ED14.5. By
16.5, however, none of these genes were differentially
expressed compared to wildtype mice. "Raw and normal-
ized microarray data from this study can be obtained from
the Gene Expression Omnibus (GEO) at the National
Center for Biotechnology Information (NCBI) database
[22].
Discussion
β-catenin is the central mediator of the canonical Wnt sig-
naling pathway and regulates many cell fate decisions dur-
Nascent acini in the β-catenin KO mouse expressβ-catenin Figure 5
Nascent acini in the β-catenin KO mouse expressβ-
catenin. Immunofluorescent staining of E12.5 pancreata 
demonstrating decreased expression of β-catenin carbox-
ypeptidase A and amylase in the β-catenin KO [CKO] as 
compared to wildtype. Note that cells expressing carbox-
ypeptidase A co-express β-catenin [arrows].BMC Developmental Biology 2007, 7:4 http://www.biomedcentral.com/1471-213X/7/4
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ing normal development in numerous tissues.
Deregulation of β-catenin/Wnt signaling is a sentinel
event in colorectal neoplasia and contributes to tumori-
genesis in many other sites. Mutations in β-catenin have
been demonstrated in exocrine pancreatic cancers, pan-
creaticoblastoma and solid-pseudopapillary tumors [23-
25]. Our laboratory has been interested in the role of Wnt
signaling in pancreatic neoplasia. Recent studies have
demonstrated the reactivation of pathways critical to nor-
mal pancreatic development, such as Notch and Hedge-
hog, during pancreatic duct carcinogenesis thus further
linking developmental pathways with pancreatic neopla-
sia [26-28].
Given the apparent role of β-catenin/Wnt signaling in cer-
tain pancreatic neoplasms, we hypothesized that this
pathway may be an important mediator of pancreatic
development. Recently, two separate reports were pub-
lished that examined the effects of genetically deleting β-
catenin in the developing pancreas, using similar methods
to those presented in the current study. In addition, a
newly published study by Heiser et al. examined the
effects of stabilized β-catenin on pancreatic development
[29]. While these studies utilized similar methods, their
conclusions had several significant differences. The cur-
rent study utilizes mouse genetics and in vitro studies of
dorsal pancreatic explants, along with gene profiling stud-
ies to suggest molecular mechanisms by which β-catenin
deletion effects mouse embryonic pancreas development.
In summary, our studies show that β-catenin expression is
required for development of the exocrine pancreas, but is
not required for development of the endocrine pancreas.
Pdx1 expressing progenitors are preserved in β-catenin KO pancreas Figure 6
Pdx1 expressing progenitors are preserved in β-catenin KO pancreas. Panel A demonstrates immunofluorescent 
staining of E 12.5 pancreas from wildtype and β-catenin KO [CKO] revealing preservation of the Pdx1 expressing cell popula-
tion. This suggests that the loss of exocrine pancreas seen later is not due to a loss of Pdx1 expressing progenitors. Panel B 
depicts E14.5 pancreas from wildtype and β-catenin KO stained for PTF1p48. Note the significant reduction in PTF1 expressing 
cells is already obvious at this developmental stage.
ABMC Developmental Biology 2007, 7:4 http://www.biomedcentral.com/1471-213X/7/4
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Our data suggests that it is inhibition of canonical Wnt
signaling that effects early exocrine cell development.
Lastly, our transcriptional profiling studies suggest several
potential roles for β-catenin in the developing pancreas
that include maintenance of undifferentiated proliferating
exocrine progenitor cells and maintenance of positional
identity along the anterior-posterior axis.
Our findings are highly concordant with that of Murtaugh
et al. who also noted severe loss of exocrine, but preserva-
tion of endocrine pancreas following conditional knock-
out of β-catenin. The findings of these two studies are in
contradistinction to the study by Dessimoz et al. in which
only modest reversible changes in exocrine pancreatic
development were present, while endocrine pancreatic
development was impaired. We believe that difference in
timing and levels of cre expression between different
Pdx1-cre lines is largely responsible for the difference in
phenotypes observed in our study versus the study of
Dessimoz et al. The Pdx1-cre strain used in this study has
been shown to direct cre-mediated recombination as early
as ED10.5 and we often observed a near complete loss of
exocrine pancreatic tissue and early lethality in β-catenin
KO animals. In contrast, the Dessimoz study found that
Cell proliferation is decreased in β-catenin KO pancreas Figure 7
Cell proliferation is decreased in β-catenin KO pancreas. Panel A and B depict hematoxylin and eosin staining [25× 
magnification] of E 14.5 pancreata from wildtype and β-catenin KO mice. Panels C and D demonstrate costaining for β-catenin 
and DAPI. Insets reveal characteristic fields immunostained for phosphohistone H3, demonstrating significantly fewer prolifer-
ating cells in the β-catenin KO pancreas.BMC Developmental Biology 2007, 7:4 http://www.biomedcentral.com/1471-213X/7/4
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Wnt signaling regulates exocrine-specific gene expression in cultured pancreatic explants Figure 8
Wnt signaling regulates exocrine-specific gene expression in cultured pancreatic explants. Immunostaining of 
e10.5 dorsal pancreatic explants exposed to the Wnt specific inhibitor, PKF 118–310 [20 nM]. Explants were established and 
then exposed to PKF 118–310 for 7 days. Treatment resulted in decreased expression of amylase, even among PTF1-express-
ing cells.BMC Developmental Biology 2007, 7:4 http://www.biomedcentral.com/1471-213X/7/4
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β-catenin KO results in a characteristic transcriptional signature in E14.5 and 16.5 pancreata Figure 9
β-catenin KO results in a characteristic transcriptional signature in E14.5 and 16.5 pancreata. Panel A depicts a 
heat map demonstrating differing transcriptional profiles of Wt and β-catenin KO pancreata at E 14.5 and 16.5. Two wildtype 
and 4 knockout samples for each timepoint are depicted. Panel B shows quantitative RT-PCR results confirming the loss of 
PTF1 expression following β-catenin KO detectable as early as E12.5.
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QPCR Confirms Differential Expression of Genes Following β-catenin KO Figure 10
QPCR Confirms Differential Expression of Genes Following β-catenin KO. Panel A-D depicts QPCR assay results for 
FgfR2, N-myc, elastase and amylase. Transcripts for FgfR2 and N-myc are reduced in the β-catenin KO animal at E14.5. In con-
trast, the pancreatic enzymes elastase and amylase show increased expression at E14.5 which is reversed by E16.5.
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animals developed pancreatitis that recovered in adult-
hood. Recently, Heiser et al. found that two different
Pdx1-cre strains caused significantly divergent phenotypes
when bred to transgenic mice harboring an allele of β-cat-
enin that can be stabilized in a cre-dependent fashion. The
investigators noted an early and late pattern of cre expres-
sion that was associated with pancreatic hypo- versus
hyperplasia, respectively. The "late" Pdx1-cre  strain uti-
lized in the Heiser study was the same strain used by
Dessimoz et al. It follows then that this line would cause
less severe perturbations in exocrine pancreatic develop-
ment as observed by these investigators. Also, inactivation
of β-catenin at later stages of development might uncover
a role for β-catenin in endocrine cell development and
explain why there were fewer endocrine cells in adult islets
in the Dessimoz et al study. It is possible that β-catenin
has several different roles throughout development of the
pancreas and that the timing of cre-mediated activation is
essential to uncover these different functions. Our find-
ings support those of both Dessimoz and Murtaugh et al.
that β-catenin, through its role in Wnt signaling, plays a
role in proliferation of developing acini, rather than in
apoptotic resistance.
Not surprisingly, the published and current studies con-
firm the previously described role for β-catenin in regulat-
ing cell proliferation. However, it is likely that there are
additional downstream consequences of β-catenin dele-
tion that remain to be identified. We have used microar-
rays to globally investigate the role of β-catenin in the
developing pancreas. To focus on direct versus indirect
effects, we analyzed embryonic pancreata lacking β-cat-
enin before and after exocrine loss were morphologically
evident. Consistent with its role in cell proliferation we
found reduced levels of genes and pathways known to reg-
ulate pancreatic cell proliferation including Ptf1, Fgfr2 and
Egf [19,30,31]. Fgfr2 is expressed in the pancreatic epithe-
lium and is activated by Fgf10 from the mesenchyme, a
signal that is important for proliferating pancreatic pro-
genitor cells [19,32,33]. Consistent with our findings,
expression of a dominant negative form of the Wnt recep-
tor Frz8 also resulted in perturbed pancreatic growth and
reduced numbers of p48 cells but did not block endocrine
differentiation [34]. We did not observe changes in the
known Wnt targets cyclin D1 or c-myc, however we did find
that N-myc, a potent regulator of proliferation, was signif-
icantly down regulated in the β-catenin KO [35-37]. A
recent study examining the role of Wnt signaling in lung
development demonstrated that like c-myc,  N-myc  is a
direct transcriptional target of β-catenin/Tcf [10].
Consistent with our observed exocrine deficiency, we
observed reduced mRNA levels of numerous exocrine
markers in β-catenin mutants. However at E14.5, prior to
any visible exocrine hypoplasia, we were surprised to see
a striking increase in mRNA levels of several markers of
exocrine differentiation including pancreatic elastase3b
Table 1: Most Downregulated Genes at E14.5 Following Deletion 
of β-catenin in Mouse Pancreas.
Gene Fold 
Change
3-phosphoglycerate dehydrogenase 9
Leucine zipper transcription factor-like 1 5.9
Adaptor-related protein complex AP-1, sigma 3 5.3
Procollagen, type IX, alpha 1 2.9
Niban protein 2.9
Hydroxyprostaglandin dehydrogenase 15 (NAD) 2.1
One cut domain, family member 1 2
Musashi homolog 2 (Drosophila) 2
Flavin containing monooxygenase 2 2
Thymopoietin 2
Solute carrier family 19 (thiamine transporter), 
member 2
2
Neuroblastoma myc-related oncogene 1 2
Regucalcin 2
Melanoma inhibitory activity 1 2
Table 2: Most Upregulated Genes at E14.5 Following Deletion of β-catenin in Mouse Pancreas.
Gene Fold Change
Elastase 3B, pancreatic 11.3
Myosin, heavy polypeptide 4, skeletal muscle 8.8
Carboxypeptidase A3, mast cell 6
CDNA sequence BC003331 5.8
Neuropeptide Y 5.8
Hypothetical gene supported by AK087915, similar to predicted human Leucine Rich Repeat protein gene ENSG00000178125 5
Histidine decarboxylase 4.8
Insulin I 4.7
Carboxypeptidase B1 (tissue) (Cpb1), mRNA. 4.6
Elastase 3B, pancreatic 4.6
Glucose-6-phosphatase, catalytic, 2 4.2
Islet amyloid polypeptide 4.2BMC Developmental Biology 2007, 7:4 http://www.biomedcentral.com/1471-213X/7/4
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(Ela3b) and amylase 2 (Amy2). Ela3b was represented 5
times on the chip and was highly up regulated at e14.5 in
each. If we relax the stringency of our clustering analysis,
numerous other proteinases were also upregulated at
E14.5 in 3 out of 4 samples. These include elastase2
(Ela2), trypsinogen 16 (Trygn16), trypsin 4 (Try4), carbox-
ypeptidase A3 and B1 (Cpa3, Cpb1), and serine protease 2
(Prss2). By E16.5, when there is obvious exocrine hypo-
plasia, all of these exocrine markers are down regulated,
demonstrating that their increased expression at E14.5 is
only transient.
Analysis of protein levels by immunohistochemistry show
that carboxypeptidase A and amylase protein levels are
reduced at E12.5 and E15.5. This could suggest that the
observed increase in exocrine markers is only at the mRNA
level, or that this is an artifact of microarray analysis.
Given the QPCR data demonstrating increases in elastase
and amylase transcript at E14.5 and the fact that there is a
substantial increase in eight separate exocrine proteinases,
it seems unlikely that this is a microarray artifact. There
are several possible explanations for a transient increase in
exocrine transcripts at E14.5. One possibility is that the
loss of a mitogenic Wnt signal triggers a failed attempt at
differentiation. Failure to effectively initiate an exocrine
differentiation program might be due to reduced levels of
p48/PTF1 in the β-catenin mutant, which is known to be
critical for the transcriptional activation of many exocrine
genes. A similar observation was made in the case of the
development of Pdx1 deficient mice, where some limited
endocrine (glucagon) and exocrine gene expression was
observed even though pancreas development was largely
arrested. In addition, although p48/PTF1 is necessary for
exocrine pancreas development, it is unlikely that all exo-
crine genes are direct targets of p48/PTF1. It is also possi-
ble that an increase in exocrine markers at E14.5 via
microarray analysis is because some remaining β-catenin
+ cells increase exocrine gene expression in attempts to
compensate for the global exocrine loss of differentiation
of exocrine progenitor cells. This is consistent with the
concept that loss of a mitogenic signal can cause perturba-
tions in proliferation, cell death or differentiation. Our
immunostaining does not support this since the remain-
ing β-catenin + cells did not show increased levels of pan-
creatic enzyme expression. Taken together our data
suggests that proliferation and differentiation, but not
apoptosis are effected in β-catenin mutants. Moreover, the
fact that some exocrine markers are reduced whereas oth-
ers are elevated suggesting that β-catenin signaling is key
at E14.5 to maintain a proper balance between prolifera-
tion and differentiation of the exocrine lineage.
In adult mice that survived past 30 days, we observed sev-
eral instances wherein the pancreatic parenchyma
appeared to be partially replaced by tissue that histologi-
cally resembles the liver and expresses albumin. This sug-
gests the possibility of hepatic transdifferentiation
suggesting that β-catenin function is required to maintain
a pancreatic phenotype. Our findings cannot exclude the
possibility that disruption of normal pancreatic develop-
ment caused by loss of β-catenin could have induced nas-
cent hepatocytes to migrate to this area. The phenomenon
of hepatic transdifferentiation has been described in other
models of severe acinar cell loss including copper or
methionine depletion and subsequent repletion but the
molecular mechanisms underlying transdifferentation in
Table 4: Most Upregulated Genes at E16.5 Following Deletion of 
β-catenin in Mouse Pancreas.
Gene Fold 
Change
Paired-like homeobox 2b 13.4
MIC2 (monoclonal Imperial Cancer Research Fund 2)-
like 1
6.1
Regulator of G-protein signaling 2 4.9
Fibulin 5 4.7
Interleukin 2 receptor, gamma chain 3.8
X-linked lymphocyte-regulated 4 3.5
Sulfatase 2 3.4
Hemoglobin Z, beta-like embryonic chain 3.4
Profilin 2 3.3
UDP-GlcNAc:betaGal beta-1,3-N-
acetylglucosaminyltransferase 5
3.2
Kelch-like 4 (Drosophila) 3.2
Heart and neural crest derivatives expressed transcript 
2
3.2
Secreted frizzled-related sequence protein 1 2.9
Table 3: Most Downregulated Genes at E16.5 Following Deletion 
of β-catenin in Mouse Pancreas.
Gene Fold 
Change
RIKEN cDNA 1810010M01 gene 100
Kallikrein 6 25
Pancreatic lipase-related protein 2 20
CUB and zona pellucida-like domains 1 0.07
Cullin 4A 0.07
Ribonuclease, RNase A family, 1 (pancreatic) 12.5
Trypsin 4 11
Chymotrypsin-like 10
Elastase 3B, pancreatic 8.5
Cytochrome P450, family 2, subfamily c, polypeptide 
70
7.7
Aquaporin 8 7.7
Elastase 2 7.7
Glycine N-methyltransferase 7.7
Protease, serine, 3 7.1
Regenerating islet-derived 1 6.7
Annexin A13 6.7
Cystathionine beta-synthase 6.3
Gamma-glutamyltransferase 1 6.3
Alcohol dehydrogenase, iron containing, 1 5.9
Insulin induced gene 1 5.9BMC Developmental Biology 2007, 7:4 http://www.biomedcentral.com/1471-213X/7/4
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adults are not well known [38,39]. A hint into a possible
mechanism comes from our microarray analyses. We have
found that at E16.5, there is a substantial increase in the
expression of Hoxb4 in the β-catenin mutant pancreas.
This homeotic transcription factor is normally expressed
the gut epithelium anterior to the Pdx1 domain and its
misexpression in the pancreas suggests that these cells
may have undergone some degree of homeotic transfor-
mation to an anterior fate [40 and Anne Grapin-Botton,
personal communication]. Consistent with this, over
expression of Wnt1 using the Pdx1 promoter causes a phe-
notype suggesting a posterior transformation of the prox-
imal foregut [41]. These data coupled with the observed
emergence of albumin expressing cells in the adult pan-
creas, suggests that β-catenin may be necessary for main-
taining positional identity of pancreatic endoderm along
the anterior-posterior axis.
The FGF pathway has been shown to regulate exocrine
pancreatic development and our finding of down regula-
tion of Fgfr2 is concordant with this [42,43]. Components
of the hedgehog, and activin signaling pathways that are
implicated in endocrine, but not exocrine development,
are reduced in β-catenin mutants [44,45]. Specifically,
Activin receptor 1c and Hhip1, are reduced in β-catenin
mutants, suggesting that these signaling components and
pathways may also play a role in exocrine development
[46].
Conclusion
In summary, our studies support a model wherein β-cat-
enin regulates proliferation and differentiation of the
developing exocrine pancreas through its role in the Wnt
signaling pathway. This observation is consistent with the
findings in human exocrine cancers wherein β-catenin/
Wnt signaling is inappropriately active and likely supports
uncontrolled proliferation. Further studies are required to
precisely define the Wnt target genes critical to prolifera-
tion of developing acini and to understand the signals that
regulate Wnt signaling functions. Our findings also raise
the question of whether modulation of β-catenin/Wnt sig-
naling in the adult pancreas could enhance recovery from
injury following diseases such as acute pancreatitis, and/
or alter the abnormal balance between proliferation and
differentiation observed in pancreatic cancer.
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